Established in Oxford, UK in 2011 by leading scientist and entrepreneur Dr Guoliang Fu
Dr Fu has over 20 years experience as a scientist in the diagnostic sector who has a track record of developing commercially valuable and patentable technologies, in the diagnostic sectors.
GeneFirst is a molecular diagnostics company working predominantly in the fields of infectious disease, cancer diagnostics and personalised medicine
ISO 13485:2003 for medical devices
GeneFirst offers robust easy-to-use, sensitive, and affordable molecular diagnostics technologies and products to researchers, clinicians and drug companies to enable accurate diagnosis and the delivery of safe and effective medicines
We sell directly into the UK market and we are currently looking to expand our business by setting up a worldwide distribution network.

We are a molecular diagnostics company focused on infectious diseases, cancer diagnostics and personalised medicine. We offer robust, easy-to-use and sensitive molecular diagnostics solutions to researchers, clinicians and drug companies to enable accurate diagnosis and delivery of safe and effective medicines.

Robust, easy-to-use, sensitive, and affordable kits
PapilloplexTM HR HPV Genotyping kit
Multiplexing – Detection and differentiation of all 14 high-risk HPV types in a single analysis (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68)
Viral load determination by a simple proprietary method
Replace your multiple-tube PCRs, sequencing and microarray hybridisation to a single real-time PCR reaction
Product pipeline of rich portfolio of patented technologies including:
TBD-Seq (Tagged BiDirectional Sequencing)
MMD-PCR (Multiplex Mutation Detection PCR)
PCDR (Polymerase Chain Displacement Reaction)

Infectious Disease
Cancer Diagnostics
Personalised Medicine